
March 11 (Reuters) - Paladin Ltd 0495.HK:
KNIGHT THERAPEUTICS INC: WILL PAY AN UPFRONT PAYMENT OF $120 MILLION IN CASH, INCLUDING INVENTORY WITH A VALUE OF $20 MILLION
KNIGHT THERAPEUTICS INC: ENTERED IN DEFINITIVE ASSET PURCHASE AGREEMENT WITH ENDO & PALADIN PHARMA TO ACQUIRE PALADIN BUSINESS
KNIGHT THERAPEUTICS INC: MAY PAY FUTURE CONTINGENT PAYMENTS OF UP TO $15 MILLION UPON ACHIEVING CERTAIN SALES MILESTONES